Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Rash | 4.6% | x | x | x | |
Pruritus | 2.8% | x | x | x | |
Acidosis | x | ||||
Haemolytic anaemia | x | x | x | ||
Blister | x | x | x | ||
Diarrhoea | x | ||||
Disseminated intravascular coagulation | x | x | x | ||
Eosinophilia | x | x | x | ||
Excoriation | x | ||||
Haemorrhage | x | ||||
Hyperventilation | x | x | x | ||
Pain | x | x | x | ||
Porphyrin metabolism disorder | x | x | x | ||
Swelling | x | x | x | ||
Erythema | x | x | x | ||
Urticaria | x | x | |||
Burning sensation | x | x | x | ||
Bone marrow depression | x | x | x | ||
Metabolic acidosis | x | x | |||
Tachypnoea | x | x | x | ||
PCO2 | x | x | |||
Face oedema | x | x | x | ||
Skin maceration | x | x | |||
Accidental ingestion | x | ||||
Glucose-6-phosphate dehydrogenase deficiency | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||
---|---|---|---|---|---|
Bacterial infection | x | x | |||
Burns third degree | x | ||||
Wound | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |